Individuals with metabolic disorders, diabetes, or other chronic conditions should consult qualified healthcare providers before considering 5-amino-1mq
No therapeutic, physiological, performance-related, cosmetic, nutritional, or veterinary claims are made or implied
The FDA does not conduct premarket review for compounded drugs to evaluate their safety, effectiveness, or quality
In animal studies, blocking NNMT raised NAD+ levels and led to lower fat mass without cutting food intake or lean muscle
No published human trials
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption